ZA985709B - Encapsulated solution dosage forms of sertraline. - Google Patents

Encapsulated solution dosage forms of sertraline.

Info

Publication number: ZA985709B
Authority: ZA; South Africa
Prior art keywords: sertraline; dosage forms; solution dosage; encapsulated solution; encapsulated
Prior art date: 1997-07-01

Application number

ZA9805709A

Other languages

English (en)

Inventor

William John Curatolo

Ravi Mysore Shanker

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-30

Publication date

2000-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985709(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-01-10 Publication of ZA985709B publication Critical patent/ZA985709B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA9805709A 1997-07-01 1998-06-30 Encapsulated solution dosage forms of sertraline. ZA985709B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
ZA985709B true ZA985709B (en)	2000-01-10

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9805709A ZA985709B (en)	1997-07-01	1998-06-30	Encapsulated solution dosage forms of sertraline.

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (xx)
JP (1)	JP3585245B2 (xx)
KR (1)	KR100371730B1 (xx)
CN (1)	CN1261792A (xx)
AP (1)	AP945A (xx)
AR (1)	AR015916A1 (xx)
AT (1)	ATE256457T1 (xx)
AU (1)	AU724635B2 (xx)
BG (1)	BG103917A (xx)
BR (1)	BR9809712A (xx)
CA (1)	CA2290973C (xx)
CO (1)	CO4940405A1 (xx)
DE (1)	DE69820608T2 (xx)
DK (1)	DK0980241T3 (xx)
DZ (1)	DZ2544A1 (xx)
EA (1)	EA001905B1 (xx)
ES (1)	ES2210760T3 (xx)
GT (1)	GT199800090A (xx)
HR (1)	HRP980378B1 (xx)
HU (1)	HUP0002250A3 (xx)
ID (1)	ID24673A (xx)
IL (1)	IL133075A0 (xx)
IS (1)	IS5266A (xx)
MA (1)	MA24586A1 (xx)
MY (1)	MY119728A (xx)
NO (1)	NO996492L (xx)
NZ (1)	NZ501252A (xx)
OA (1)	OA11246A (xx)
PA (1)	PA8454001A1 (xx)
PE (1)	PE97299A1 (xx)
PL (1)	PL337807A1 (xx)
PT (1)	PT980241E (xx)
SK (1)	SK282914B6 (xx)
TN (1)	TNSN98123A1 (xx)
TR (1)	TR199903282T2 (xx)
TW (1)	TW382597B (xx)
UA (1)	UA68350C2 (xx)
UY (1)	UY25070A1 (xx)
WO (1)	WO1999001113A1 (xx)
ZA (1)	ZA985709B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
PL348119A1 (en) *	1998-10-13	2002-05-06	Pfizer Prod Inc	Sertraline oral concentrate
IL148159A0 (en)	1999-09-03	2002-09-12	Lilly Co Eli	Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
AP2001002264A0 (en)	2000-08-30	2001-09-30	Pfizer Prod Inc	Sustained release formulations for growth hormone secretagogues.
EP1375659A1 (en) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
JP2006507309A (ja) *	2002-10-31	2006-03-02	アルザ・コーポレーシヨン	疎水性薬剤の上昇した生物学的利用性を提供する製剤
WO2016020936A2 (en) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0782445B1 (en) *	1994-09-19	2002-03-13	Dupont Pharmaceuticals Company	Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
DK0768083T3 (da) *	1995-07-17	2003-06-23	Pfizer	Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt

1998
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Ceased
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
1999
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HRP980378A2 (en)	1999-04-30
KR100371730B1 (ko)	2003-02-07
TW382597B (en)	2000-02-21
GT199800090A (es)	1999-12-21
BG103917A (bg)	2000-07-31
OA11246A (en)	2002-11-19
WO1999001113A1 (en)	1999-01-14
AR015916A1 (es)	2001-05-30
CN1261792A (zh)	2000-08-02
HUP0002250A2 (hu)	2000-12-28
EP0980241B1 (en)	2003-12-17
AU7545098A (en)	1999-01-25
DE69820608T2 (de)	2004-12-23
CA2290973C (en)	2003-06-17
ID24673A (id)	2000-07-27
CO4940405A1 (es)	2000-07-24
PL337807A1 (en)	2000-09-11
DZ2544A1 (fr)	2003-02-08
DE69820608D1 (de)	2004-01-29
NO996492D0 (no)	1999-12-27
JP3585245B2 (ja)	2004-11-04
MY119728A (en)	2005-07-29
PA8454001A1 (es)	2000-05-24
SK282914B6 (sk)	2003-01-09
BR9809712A (pt)	2000-07-11
UA68350C2 (en)	2004-08-16
UY25070A1 (es)	2000-12-29
PE97299A1 (es)	1999-10-13
PT980241E (pt)	2004-03-31
TR199903282T2 (xx)	2000-08-21
ES2210760T3 (es)	2004-07-01
EA001905B1 (ru)	2001-10-22
HUP0002250A3 (en)	2001-01-29
KR20010013588A (ko)	2001-02-26
CA2290973A1 (en)	1999-01-14
EP0980241A1 (en)	2000-02-23
SK180599A3 (en)	2001-01-18
DK0980241T3 (da)	2004-04-05
IL133075A0 (en)	2001-03-19
IS5266A (is)	1999-11-23
MA24586A1 (fr)	1998-12-31
NO996492L (no)	2000-02-29
AP945A (en)	2001-02-28
ATE256457T1 (de)	2004-01-15
TNSN98123A1 (fr)	2005-03-15
AP9801279A0 (en)	1998-06-30
NZ501252A (en)	2004-11-26
JP2000512316A (ja)	2000-09-19
AU724635B2 (en)	2000-09-28
EA199900963A1 (ru)	2000-08-28
HRP980378B1 (en)	2001-12-31

Publication	Publication Date	Title
PH30784A (en)	1997-10-17	Encapsulated dosage forms.
ZA99454B (en)	2000-10-23	Novel dosage form.
ZA989251B (en)	2000-04-10	Potentiation of pharmaceuticals.
ZA982253B (en)	1999-09-17	Therapeutic compositions.
IL121145A0 (en)	1997-11-20	Multiphase soft gelatin dosage form
ZA9811504B (en)	2000-06-15	Novel pharmaceutical.
ZA9811506B (en)	2000-11-06	Novel pharmaceutical.
ZA985710B (en)	2000-01-10	Delayed-release dosage forms of sertraline.
ZA9811505B (en)	2000-11-06	Novel pharmaceutical.
ZA985709B (en)	2000-01-10	Encapsulated solution dosage forms of sertraline.
PL338781A1 (en)	2000-11-20	Dosage form
SI0980241T1 (en)	2004-04-30	Gelatine encapsulated solution dosage forms of sertraline
ZA982558B (en)	1999-09-27	Novel Pharmaceutical.
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
GB9718683D0 (en)	1997-11-05	Novel dosage form
GB9719261D0 (en)	1997-11-12	Dosage forms
GB9704978D0 (en)	1997-04-30	Dosage forms
EG23239A (en)	2004-09-29	Preparation of haemagel.
CA82556S (en)	1997-12-05	Capsule
GB2329335B (en)	2000-06-21	Medicament
IL120398A0 (en)	1997-07-13	Low dosage contraceptive
HUP9903097A3 (en)	2000-02-28	Medicament containing progestogen-anti-progestogen
GB9717408D0 (en)	1997-10-22	Active trioxanes
GB9726234D0 (en)	1998-02-11	Medicament
GB9702946D0 (en)	1997-04-02	Medicament